Prof. Dr.
Prof Joe O'Sullivan
Oncology
- 🇬🇧
- GP consultation
- Annual physical exam
- Vaccination administration
- Minor procedure (skin)
About Prof Joe O'Sullivan
Prof. Joe O'Sullivan is a renowned figure in the field of Oncology. Their work is primarily focused on the treatment of prostate cancer. Prof. O'Sullivan is considered a leading expert in the use of ionising radiation in the treatment of advanced prostate cancer. Prof. O'Sullivan is particularly interested in advancing the use of radionuclide therapy for metastatic prostate cancer. Their research also extends to translational research in prostate cancer and radiotherapy, and clinical trials for advanced prostate cancer. They have contributed significantly to the field, having authored over 200 research papers. Prof. O'Sullivan qualified in medicine from University College Dublin in 1993. They subsequently trained in Radiation Oncology at St. Luke's Hospital in Dublin. Prof. O'Sullivan is a member of the Advanced Prostate Cancer Consensus Conference (APCCC) voting panel.
"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."
Credentials & verification
Medical license
Organización Médica Colegial de España (OMC) ·
#-105007
Valid until 2028-12-31
Verify with issuerBoard certification
European Board of Oncology
#EB-0BF80383
Renewal due 2022
Verify with issuerMalpractice cover
Allianz Professional
2,000,000 EUR
Valid until 2026-12-31
No claims on file
Education & training
-
2001–2007
MD · Medicine and Surgery
Universitat de València
-
2007–2011
Residency · Oncology
Universitat de València
Career & appointments
-
2011-09–2012-08
Junior consultant
Universitat de València Teaching Hospital — Oncology
Procedures & conditions
| Procedure | Code | Lifetime volume |
|---|---|---|
| GP consultation | 99213 |
719 |
| Annual physical exam | 99395 |
2,377 |
| Vaccination administration | 90471 |
2,569 |
| Minor procedure (skin) | 17110 |
2,822 |
Patient reviews
"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."
"Took time to listen and reviewed all my previous results. I would absolutely recommend."
"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."
Recognition & press
Awards
- Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2012
- national college of family doctors — Member · since 2012
- European Union of Medical Specialists (UEMS) — Member · since 2012
Your consultation, step by step
- 1 Choose a slot
- 2 Brief pre-consult form
- 3 Consultation
- 4 Follow-up note & plan
Services & pricing
New patient consultation (60m)
Follow-up consultation (30m)
Vaccination administration
Minor procedure (skin)
Research & publications
h-index: 3 · i10: 5
Selected publications
-
Long-term follow-up of Oncology across
DOI: 10.5085/euroclin.2026.0 · cited by 183
-
Validation of clinical scoring in Oncology
DOI: 10.8157/euroclin.2025.1 · cited by 197
-
Long-term follow-up of Oncology across
DOI: 10.5012/euroclin.2024.2 · cited by 35
Show full research record
Invited talks
- Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
- Single-centre experience in Oncology · National Society Meeting · · 2023
Articles by Prof Joe O'Sullivan
Frequently asked
01. Do you accept new patients?
Prof Joe O'Sullivan is currently accepting new patients. Use the booking module to choose a slot.
02. Which languages can I be seen in?
Consultations are available in English.
03. Is the consultation in-person or online?
Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.
04. Do you accept my insurance?
Please use the booking flow to enter your insurance — we verify and confirm before your slot.
05. What is the cancellation policy?
Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.
06. How is my health data protected?
All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.